New and Revised FDA Import Alerts for April 12-13
On April 12-13 the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-32: Products from firms Refusing FDA Foreign Establishment Inspection (here)
- 99-21: Food Products Containing Sulfites (here)
- 99-19: Food Products due to the Presence of Salmonella (here)
- 66-66: APIs That Appear to Be Misbranded Under 502(f)(1) Because They do not Meet the Requirements for the Labeling Exemptions in 21 CFR 201.122 (here)
- 66-40: Drugs from firms Which Have Not Met Drug Good Manufacturing Practices (GMPs) (here)
- 66-10: Chinese Herbal Medicines (here)
- 45-07: Illegal Undeclared Sweeteners (here)
- 45-02: Foods Containing Illegal and/or Undeclared Colors (here)
- 36-04: Honey and Blended Syrup due to Unsafe Drug Residues (here)
- 24-23: Cilantro From the State of Puebla, Mexico -- Seasonal (April 1 - Aug. 30) (here)
- 12-10: Cheese due to Microbiological Contamination (here).